Department of Urogynaecology, St George Hospital, University of New South Wales, Sydney, NSW, Australia.
BJOG. 2009 Dec;116(13):1715-21. doi: 10.1111/j.1471-0528.2009.02380.x.
To evaluate, at a minimum of 6 years, the long-term discontinuation rates and incidence of adverse events associated with vaginal ring pessary use.
Retrospective case identification.
Tertiary urogynaecology unit.
All women fitted with either a Portex ring pessary or Introl bladder neck support device during the index period (1992-2002).
Retrospective chart review.
Length of use and complications of pessary use, including bleeding, extrusion, malodorous vaginal discharge, constipation and incontinence.
Of the 273 women fitted with a ring pessary, 167 were successfully using it at 4 weeks; subsequently, 93 (56%) experienced complications comprising bleeding, extrusion, severe vaginal discharge, pain and constipation, in that order, although 38 women (23%) had more than one type of complication and most had more than one episode. Only 23 of 167 (14%) continued with pessary use at the study endpoint (November 2008). The median duration of use was 7 years (interquartile range, 6-9 years; range, 2.25-13.9 years). Of those who discontinued, the median duration was 1.4 years (range, 0.1-11 years; interquartile range, 0.5-3.6 years). After cessation, 73 (44%) chose conservative treatment and 50 (30%) chose surgery. Twelve women died during the time frame; nine returned to their GP.
We were surprised to find a 56% complication rate in pessary users. Our study shows that, over time, the majority of women chose to discontinue using pessaries. Women should be informed of these data when deciding on the management of their pelvic organ prolapse.
评估阴道环子宫托至少 6 年的长期停药率和与使用相关的不良事件发生率。
回顾性病例识别。
三级泌尿妇科单位。
所有在索引期(1992-2002 年)期间佩戴 Portex 环子宫托或 Introl 膀胱颈支撑装置的女性。
回顾性图表审查。
子宫托使用时间和并发症,包括出血、脱出、恶臭阴道分泌物、便秘和尿失禁。
在 273 名佩戴环子宫托的女性中,有 167 名在 4 周时成功使用;随后,93 名(56%)出现并发症,包括出血、脱出、严重阴道分泌物、疼痛和便秘,依次排列,尽管 38 名女性(23%)有多种类型的并发症,大多数有多个发作。在研究终点(2008 年 11 月),只有 23 名 167 名女性(14%)继续使用子宫托。使用中位数为 7 年(四分位距,6-9 年;范围,2.25-13.9 年)。在停药的患者中,中位数为 1.4 年(范围,0.1-11 年;四分位距,0.5-3.6 年)。停药后,73 名(44%)选择保守治疗,50 名(30%)选择手术。在研究期间,有 12 名女性死亡;9 名返回他们的家庭医生。
我们惊讶地发现子宫托使用者的并发症发生率为 56%。我们的研究表明,随着时间的推移,大多数女性选择停止使用子宫托。在决定其盆腔器官脱垂的治疗方案时,应将这些数据告知女性。